Reply to: "Clinical characteristics of COVID-19 patients with abnormal liver tests"
- PMID: 32387074
- PMCID: PMC7201227
- DOI: 10.1016/j.jhep.2020.04.042
Reply to: "Clinical characteristics of COVID-19 patients with abnormal liver tests"
Conflict of interest statement
Conflict of interest The authors declare no conflicts of interest that pertain to this work. Please refer to the accompanying ICMJE disclosure forms for further details.
Comment on
-
Clinical characteristics of COVID-19 patients with abnormal liver tests.J Hepatol. 2020 Sep;73(3):712-713. doi: 10.1016/j.jhep.2020.04.028. Epub 2020 Apr 26. J Hepatol. 2020. PMID: 32348791 Free PMC article. No abstract available.
References
-
- Cai Q., Huang D., Ou P., Yu H., Zhu Z.B., Xia Z. COVID-19 in a designated infectious diseases hospital outside Hubei Province, China. Allergy. 2020;75(7):1742–1752. - PubMed
-
- Metlay J.P., Waterer G.W., Long A.C., Anzueto A., Brozek J., Crothers K. Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019;200(7):e45–e67. - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources